Suchergebnisse - "*Ritonavir"

PubPharm (86)

81

Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children

enthalten in: BMC infectious diseases | 2008

von Gonzalez-Tome, M. | Amador, J. | Peña, M. | +3

82

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

enthalten in: BMC infectious diseases | 2007

von Larru, B. | de Mendoza, C. | Bellón, J. | +5

83

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

enthalten in: BMC infectious diseases | 2007

von Larru, B. | de Mendoza, C. | Bellón, J. | +5

84

Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients

enthalten in: BMC infectious diseases | 2003

von Nadler, J. | Gathe, J. | Pollard, R. | +7

85

Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients

enthalten in: BMC infectious diseases | 2003

von Nadler, J. | Gathe, J. | Pollard, R. | +6

86

Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients

enthalten in: BMC infectious diseases | 2003

von Nadler, J. | Gathe, J. | Pollard, R. | +6

[1]
« Vorheriger
1
2
3
4
5
6
7
8
9